Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Sempra (SRE.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-2581.2393.50Buy
2022-04-0483.3899.00Buy
2022-06-3075.1496.00Buy
2022-08-1283.19102.00Buy
2022-10-1971.8789.00Buy
2022-10-2876.2091.00Buy
2022-11-0376.3192.50Buy
2022-11-1177.3394.00Buy
2022-12-0282.9797.50Buy
2022-12-1678.6698.00Buy
2023-01-0677.2796.50Buy
2023-01-2079.0096.00Buy
2023-02-0377.9596.50Buy
2023-03-1772.6795.00Buy
2023-03-2172.8090.50Buy
2023-06-0672.5499.00Buy
2023-06-2371.88100.00Buy
2023-08-1870.7296.00Buy
2023-09-0871.2595.00Buy
2023-10-0466.4989.00Buy
2024-02-1670.4994.00Buy
2024-04-0470.8489.00Buy
2024-07-1977.5795.00Buy
2025-02-2672.8578.00Neutral
2025-06-2476.0982.00Neutral

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.